Mirae Asset Global Investments’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.57M | Sell |
|
|||||
|
2025
Q1 | $1.52M | Sell |
|
|||||
|
2024
Q4 | $2.25M | Buy |
|
|||||
|
2024
Q3 | $1.55M | Buy |
|
|||||
|
2024
Q2 | $515K | Sell |
|
|||||
|
2024
Q1 | $1.52M | Sell |
|
|||||
|
2023
Q4 | $3.56M | Sell |
|
|||||
|
2023
Q3 | $3.3M | Sell |
|
|||||
|
2023
Q2 | $3.36M | Sell |
|
|||||
|
2023
Q1 | $3.94M | Buy |
|
|||||
|
2022
Q4 | $3.19M | Sell |
|
|||||
|
2022
Q3 | $3.39M | Sell |
|
|||||
|
2022
Q2 | $3.62M | Sell |
|
|||||
|
2022
Q1 | $3.6M | Sell |
|
|||||
|
2021
Q4 | $3.69M | Sell |
|
|||||
|
2021
Q3 | $4.43M | Buy |
|
|||||
|
2021
Q2 | $3.94M | Sell |
|
|||||
|
2021
Q1 | $4.05M | Sell |
|
|||||
|
2020
Q4 | $4.92M | Buy |
|
|||||
|
2020
Q3 | $3.83M | Buy |
|
|||||
|
2020
Q2 | $4.69M | Sell |
|
|||||
|
2020
Q1 | $4M | Sell |
|
|||||
|
2019
Q4 | $25.7M | Sell |
|
|||||
|
2019
Q3 | $22.2M | Sell |
|
|||||
|
2019
Q2 | $25.5M | Sell |
|
|||||
|
2019
Q1 | $27M | Buy |
|
|||||
|
2018
Q4 | $19M | Buy |
|
|||||
|
2018
Q3 | $30.7M | Buy |
|
|||||
|
2018
Q2 | $8.41M | Buy |
|
|||||
|
2018
Q1 | $6.66M | Buy |
|
|||||
|
2017
Q4 | $4.14M | Buy |
|
|||||
|
2017
Q3 | $961K | Buy |
|